Home » Newsletters » BioWorld Science

BioWorld Science

June 18, 1997

View Archived Issues

Hoechst prepares compounds for degenerative and inflammatory disorders

Vasopressin and/or oxytocin receptor ligands described by Sanofi

General Hospital Corp. and Shiseido disclose psoriastatin polypeptides

Tazorac approved in the U.S.

Update on SIBIA Neurosciences' SIB-1508Y

First clinical trials results reported for leptin

RPR seeks approval for enoxaparin for unstable angina in Europe

Synsorb Biotech receives U.S. patent coverage for treatment of diarrhea

Results from phase II trial with thalidomide for prostate cancer reported

Targets for antimigraine therapy: inhibitors of neurogenic plasma protein extravasation

DuPont Merck's breast imaging agent approved in the U.K.

Targets for antimigraine therapy: NK1 blockade not an effective antimigraine strategy

Coreg now available in the U.S. for heart failure

Targets for antimigraine therapy: NOS inhibitors as new therapeutic approach

Novartis and Osiris Therapeutics to codevelop bone and cartilage disease therapies

Targets for antimigraine therapy: SSRIs in the prevention of migraine

High-dose riboflavin for migraine prophylaxis

NeoPharm begins phase I/II trial for liposome-encapsulated doxorubicin

Novel CCK-B antagonist with anxiolytic activity from Rotta

Dainippon Ink presents new antiallergic/antiasthmatic agent

LMW inhibitor of Tat-TAR interaction and HIV replication prepared at Novartis

PPL Therapeutics authorized to start phase II trials with transgenic product

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...